Drew University of Medicine and Science, Department of Otolaryngology, Los Angeles, CA, USA. email@example.com
"S. cerevisiae is a promising anti-cancer agent that induces significant levels of apoptosis in malignant cells in vivo. However, yeast therapy for the treatment of breast cancer has yet to pass controlled clinical trials."
GlobeImmune, Inc., 12635 E. Montview Blvd, Aurora, CO 80010, USA.
"Recombinant yeast cells are capable of stimulating the immune system to produce highly specific and potent cellular responses against target protein antigens with little toxicity. Data from animal models suggest that Tarmogens (yeast-based immunotherapeutics) can elicit protective immunity against xenografted and chemically induced tumours."